Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of viral coinfection in post-pandemic invasive Group A streptococcal infections in adults, a nation-wide cohort study (iGASWISS).

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

Feasibility and Safety of the "One-Week Breast Radiation Therapy" Program.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

COVID-19 isolation measures did not prevent vancomycin-resistant enterococci transmissions.

The Journal of hospital infection·2023
Same author

Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Nosocomial influenza in south-western Swiss hospitals during two seasonal epidemics: an observational study.

The Journal of hospital infection·2021

Related Experiment Video

Updated: Jul 7, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

[Infectious diseases (beside AIDS)].

C Bellini1, L Senn, G Zanetti

  • 1Service de médecine préventive hospitalière, CHUV, 1011 Lausanne. Cristina.Bellini@chuv.ch

Revue Medicale Suisse
|February 7, 2008
PubMed
Summary
This summary is machine-generated.

Updated infectious endocarditis guidelines and new antifungal prophylaxis are discussed. Emerging infectious diseases and innate immunity

More Related Videos

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Related Experiment Videos

Last Updated: Jul 7, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Immunology

Background:

  • Recent updates to US guidelines for infectious endocarditis prophylaxis are noted.
  • New antifungal agents like posaconazole offer prophylaxis options for immunocompromised individuals.
  • Epidemiological trends in sexually transmitted infections necessitate targeted screening strategies.

Purpose of the Study:

  • To review current and upcoming changes in infectious disease prophylaxis and treatment guidelines.
  • To highlight emerging infectious disease threats and their implications.
  • To explore the role of innate immunity in individual susceptibility to infections.

Main Methods:

  • Review of published guidelines and epidemiological data.
  • Analysis of meta-analysis findings on antibiotic therapy for Campylobacter infections.
  • Discussion of emerging infectious disease trends and basic research in innate immunity.

Main Results:

  • Anticipated changes in Swiss guidelines for endocarditis prophylaxis.
  • Posaconazole as a key antifungal agent for prophylaxis in specific patient groups.
  • Clarification of antibiotic therapy impact in Campylobacter infections.
  • Identification of Norovirus, ESBL-producing bacteria, resistant tuberculosis, and novel respiratory viruses as key emerging threats.
  • Exploration of the link between innate immunity and infection susceptibility.

Conclusions:

  • The field of infectious diseases is dynamic, requiring continuous guideline updates and awareness of emerging threats.
  • New prophylactic agents and a better understanding of innate immunity hold promise for future infection control.
  • A comprehensive approach integrating updated guidelines, new therapies, and basic research is crucial for combating infectious diseases.